Clinical Trials Browser

Phase NA × Active not recruiting × Triple Negative Breast Neoplasms × Clear all

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07484776 2026-03-20

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

Phase NA Active not recruiting

40 enrolled

Breast

Triple Negative Breast Neoplasms

NCT02455791 2026-03-09

Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery

Phase NA Active not recruiting

43 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06418126 2026-01-05

TNBC-RT2023

Phase NA Active not recruiting

15 enrolled

Breast

Triple Negative Breast Neoplasms

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Phase NA Active not recruiting

798 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03077776 2025-02-20

TRACERX-TNBC

Phase NA Active not recruiting

149 enrolled

Breast

Triple Negative Breast Neoplasms

NCT03881605 2025-01-20

SYMPToM

Phase NA Active not recruiting

50 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06782698 2025-01-20

HoPEx-Breast

Phase NA Active not recruiting

50 enrolled

Breast

Breast Neoplasms, Fatigue, Motor Activity, Triple Negative Breast Neoplasms

NCT05955521 2023-07-21

Exosome as the Prognostic and Predictive Biomarker in EBC Patients

Phase NA Active not recruiting

200 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery

TNBC-RT2023

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

TRACERX-TNBC

SYMPToM

HoPEx-Breast

Exosome as the Prognostic and Predictive Biomarker in EBC Patients